AbbVie, Novo Nordisk TV ads generate most searches in first half of 2022, ad tracker finds

29 Jul 2022

Most pharma TV commercials include a link at the end of the ad, offering a website link for viewers who want more information. It turns out millions of them do. So far in 2022, AbbVie, Novo Nordisk and AstraZeneca are leading the pharma pack with the most engagements garnered, according to data for the first half of 2022 from TV ad tracker EDO. AbbVie’s Allergan Vuity eyedrops for age-related blurry vision drove the most searches among pharma TV advertising, generating 3.43 million searches after ad runs. That’s more than double the total for the next searched TV ad at No. 2, Novo Nordisk’s Ozempic, which notched 1.7 million, in EDO’s research.

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

AstraZeneca PLC

AbbVie, Inc.

Novo Nordisk A/S

[+1]

Indications

Alzheimer Disease, Familial, Type 3

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.